Efficacy and safety of generic and original pioglitazone in type 2 diabetes mellitus: A multicenter, a double-blinded, randomized-controlled study

• Main Authors: Rawdaree P., Deerochanawong C., Peerapatdit T., Thongtang N., Suwanwalaikorn S., Khemkha A., Benjasuratwong Y., Boonyavarakul A., Chetthakul T., Leelawattana R., Ngarmukos C., Viwatwongkasem C., Pratipanawatr T., Kosachunhanun N.
• 格式: Article
• 語言: English
• 出版: 2014
• 在線閱讀: http://www.scopus.com/inward/record.url?eid=2-s2.0-78649246535&partnerID=40&md5=caba8fc5f4da12b89945f313a052fe98; http://cmuir.cmu.ac.th/handle/6653943832/3620
• 機構: Chiang Mai University

Objective: To compare the efficacy and safety of generic (Utmos®) and original (Actos®) 30 mg Pioglitazone tablets. Study design: A multicenter, parallel randomized, double-blinded, controlled study. Material and Method: Type 2 diabetic patients, with glycosylated hemoglobin (HbA1c) ≥ 7.0%, who rece...